Technetium Tc 99m Succimer Injection
meso-2,3-Dimercaptosuccinic acid, 99mTc complex.
» Technetium Tc 99m Succimer Injection is a sterile, clear, colorless, aqueous solution of succimer complexed with 99mTc. It is suitable for intravenous administration. It contains not less than 85.0 percent of the labeled amount of 99mTc as the succimer complex expressed in megabecquerels (microcuries or millicuries) per mL at the time indicated in the labeling. It may contain reducing agents. Other chemical forms of radioactivity do not exceed 15.0 percent of the total radioactivity.
Packaging and storage—
Preserve in single-dose containers, at a temperature between 15
and 30. Do not freeze or store above 30. Protect from light.
and 30. Do not freeze or store above 30. Protect from light.
Labeling—
Label it to include the following, in addition to the information specified for Labeling under Injections 
1
: the time and date of calibration; the amount of 99mTc as labeled succimer expressed as total megabecquerels (microcuries or millicuries) and concentration as megabecquerels (microcuries or millicuries) per mL at the time of calibration; the expiration date and time; and the statement “Caution—Radioactive Material.” The labeling indicates that in making dosage calculations, correction is to be made for radioactive decay, and also indicates that the radioactive half-life of 99mTc is 6.0 hours. In addition, the labeling states that it is not to be used if discoloration or particulate matter is observed. [note—A beyond-use time of 30 minutes shall be stated on the label upon constitution with Sodium Pertechnetate Tc 99m Injection.]
1: the time and date of calibration; the amount of 99mTc as labeled succimer expressed as total megabecquerels (microcuries or millicuries) and concentration as megabecquerels (microcuries or millicuries) per mL at the time of calibration; the expiration date and time; and the statement “Caution—Radioactive Material.” The labeling indicates that in making dosage calculations, correction is to be made for radioactive decay, and also indicates that the radioactive half-life of 99mTc is 6.0 hours. In addition, the labeling states that it is not to be used if discoloration or particulate matter is observed. [note—A beyond-use time of 30 minutes shall be stated on the label upon constitution with Sodium Pertechnetate Tc 99m Injection.]
Bacterial endotoxins 85—
The limit of endotoxin content is not more than 175/V USP Endotoxin Unit per mL of the Injection, when compared with the USP Endotoxin RS, in which V is the maximum recommended total dose, in mL, at the expiration date or time.
85—
The limit of endotoxin content is not more than 175/V USP Endotoxin Unit per mL of the Injection, when compared with the USP Endotoxin RS, in which V is the maximum recommended total dose, in mL, at the expiration date or time.
pH 791:
between 2.0 and 3.0.
791:
between 2.0 and 3.0.
Radiochemical purity—
Activate a 65- × 95-mm silicic acid thin-layer chromatographic plate by heating at 100-110 for 30 minutes. Cool over silica gel and immediately apply 1 µL of Injection, appropriately diluted, if necessary, to a radioactive concentration of 18.5 to 370 MBq (0.5 to 10 mCi) per mL, about 17 mm from one end of the chromatographic plate, and allow to dry. Develop the chromatogram over a period of about 30 to 45 minutes by ascending chromatography, using n-butanol saturated with 0.3 N hydrochloric acid, and air-dry. Determine the radioactive distribution by scanning the chromatogram with a suitable collimated radiation detector. Not less than 85% of the total radioactivity is found as succimer at an RF between 0.45 and 0.70. Hydrolyzed 99mTc is located at the origin (RF 0 to 0.15) and the unbound 99mTc is located at the solvent front (RF 1.0).
for 30 minutes. Cool over silica gel and immediately apply 1 µL of Injection, appropriately diluted, if necessary, to a radioactive concentration of 18.5 to 370 MBq (0.5 to 10 mCi) per mL, about 17 mm from one end of the chromatographic plate, and allow to dry. Develop the chromatogram over a period of about 30 to 45 minutes by ascending chromatography, using n-butanol saturated with 0.3 N hydrochloric acid, and air-dry. Determine the radioactive distribution by scanning the chromatogram with a suitable collimated radiation detector. Not less than 85% of the total radioactivity is found as succimer at an RF between 0.45 and 0.70. Hydrolyzed 99mTc is located at the origin (RF 0 to 0.15) and the unbound 99mTc is located at the solvent front (RF 1.0).
Biological distribution—
Inject intravenously between 3.7 MBq and 92.5 MBq (100 µCi and 2500 µCi) of Injection, in a volume of 0.2 to 0.25 mL, into the caudal vein of each of three 125-g to 225-g anesthetized Sprague-Dawley female rats. Clamp the opening of the urethra with a hemostat. Sacrifice the animals 1 hour after the injection, and carefully remove the kidneys, bladder, and liver and spleen of each as three separate organs by dissections. Place each organ and the remaining carcass (excluding the tail) in separate, suitable counting containers, and determine the radioactivity, in counts per minute, in each container with an appropriate detector, using the same counting geometry. Determine the percentage of administered radioactive dose in each organ: not less than 40% of the administered radioactive dose is found in the kidneys and a ratio of not less than 6:1 of the administered dose is found in the ratio kidneys/(liver and spleen), in not fewer than two of the animals.
Other requirements—
It meets the requirements of the tests for Radionuclide identification and Radionuclidic purity under Sodium Pertechnetate Tc 99m Injection. It meets also the requirements under Injections 1, except that it may be distributed or dispensed prior to completion of the test for Sterility, the latter test being started on the day of final manufacture, and except that it is not subject to the recommendation on Volume in Container.
1, except that it may be distributed or dispensed prior to completion of the test for Sterility, the latter test being started on the day of final manufacture, and except that it is not subject to the recommendation on Volume in Container.
Assay for radioactivity 821—
Using a suitable counting assembly (see Selection of a Counting Assembly), determine the radioactivity, in MBq (µCi) per mL, of Injection by use of a calibrated system.
821—
Using a suitable counting assembly (see Selection of a Counting Assembly), determine the radioactivity, in MBq (µCi) per mL, of Injection by use of a calibrated system.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
| Monograph | Ian DeVeau, Ph.D.
Director, Veterinary Drugs and Radiopharmaceuticals 1-301-816-8178 |
(RMI05) Radiopharmaceuticals and Medical Imaging Agents 05 |
| Reference Standards | Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org |
|
| 85 |
Radhakrishna S Tirumalai, Ph.D.
Senior Scientist 1-301-816-8339 |
(MSA05) Microbiology and Sterility Assurance |
USP32–NF27 Page 3672